Frontiers in Pharmacology | Inflammation Pharmacology

Original Research

Published on 29 Nov 2023

ACT001 improved cardiovascular function in septic mice by inhibiting the production of proinflammatory cytokines and the expression of JAK-STAT signaling pathway

in Inflammation Pharmacology

Zhen Peng
Xiaolong Lv
Xintong Wang
Ting Shang
Jing Chang
Khalid Salahdiin
Yue Guo
Zhisen Zhang
Ru Shen
Ming Lyu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1265177

4,128 views
5 citations

Original Research

Published on 20 Nov 2023

IL-37 counteracts inflammatory injury in the temporomandibular joint via the intracellular pathway

in Inflammation Pharmacology

Jun Li
Sisi Peng
Ying Yan
Shan Yan
Xin Cao
Yong Li
Luying Zhu
Jie Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1250216

2,283 views

Review

Published on 16 Nov 2023

Current and promising therapies based on the pathogenesis of Graves’ ophthalmopathy

in Inflammation Pharmacology

Xin Zhang
Qixiang Zhao
Bei Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1217253

6,240 views
8 citations

Review

Published on 15 Nov 2023

Immunomodulatory roles of metalloproteinases in rheumatoid arthritis

in Inflammation Pharmacology

Yanqin Bian
Zheng Xiang
Yaofeng Wang
Qing Ren
Guoming Chen
Bei Xiang
Jianye Wang
Chengbo Zhang
Shaoqiang Pei
Shicheng Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1285455

8,259 views
21 citations

Original Research

Published on 10 Nov 2023

Suppression of inflammation-induced lung cancer cells proliferation and metastasis by exiguaflavanone A and exiguaflavanone B from Sophora exigua root extract through NLRP3 inflammasome pathway inhibition

in Inflammation Pharmacology

Punnida Arjsri
Kamonwan Srisawad
Warathit Semmarath
Sonthaya Umsumarng
Lapamas Rueankham
Aroonchai Saiai
Methee Rungrojsakul
Trinnakorn Katekunlaphan
Songyot Anuchapreeda
Pornngarm Dejkriengkraikul

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1243727

3,275 views
7 citations

Mini Review

Published on 06 Nov 2023

Mechanisms of action of the BCL-2 inhibitor venetoclax in multiple myeloma: a literature review

in Inflammation Pharmacology

Qiang Cao
Xinyan Wu
Qi Zhang
Junling Gong
Yuquan Chen
Yanwei You
Jun Shen
Yi Qiang
Guangzhu Cao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1291920

8,183 views
21 citations

Mini Review

Published on 06 Nov 2023

Role of signaling lymphocytic activation molecule family of receptors in the pathogenesis of rheumatoid arthritis: insights and application

in Inflammation Pharmacology

Yixin Zheng
Jianan Zhao
Mi Zhou
Kai Wei
Ping Jiang
Lingxia Xu
Cen Chang
Yu Shan
Linshuai Xu
Yiming Shi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1306584

3,931 views
11 citations

Brief Research Report

Published on 01 Nov 2023

Large chemokine binding spectrum of human and mouse atypical chemokine receptor GPR182 (ACKR5)

in Inflammation Pharmacology

Remy Bonnavion
Shangmin Liu
Haruya Kawase
Kenneth Anthony Roquid
Stefan Offermanns

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1297596

3,432 views
6 citations

Original Research

Published on 30 Oct 2023

Association of lipid lowering drugs and the risk of systemic lupus erythematosus: a drug target Mendelian randomization

in Inflammation Pharmacology

Tong Wu
Ling Ye
Shenglan Wang
Jie Huang
Jing Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1258018

5,605 views
3 citations

Original Research

Published on 26 Oct 2023

β-sitosterol alleviates dextran sulfate sodium-induced experimental colitis via inhibition of NLRP3/Caspase-1/GSDMD-mediated pyroptosis

in Inflammation Pharmacology

Di Zhang
Fei Ge
Jing Ji
Yu-Jing Li
Fu-Rong Zhang
Shu-Yan Wang
Shu-Jing Zhang
Dong-Mei Zhang
Meng Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1218477

5,773 views
18 citations

Correction

Published on 26 Oct 2023

Corrigendum: Naringenin protects against acute pancreatitis-associated intestinal injury by inhibiting NLRP3 inflammasome activation via AhR signaling

in Inflammation Pharmacology

Xu Yan
Tianjiao Lin
Qingyun Zhu
Yushi Zhang
Zhimin Song
Xinting Pan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1295494

1,093 views
8 citations

Opinion

Published on 23 Oct 2023

Whether MTHFD2 plays a new role: from anticancer targets to anti-inflammatory disease

in Inflammation Pharmacology

Hui Tang
Ning Hou

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1257107

2,542 views

Original Research

Published on 23 Oct 2023

Non-aromatizable androgens modulate the lipopolysaccharide induced expression of the P2X7 receptor in human adipocytes

in Inflammation Pharmacology

Angelo Di Vincenzo
Marnie Granzotto
Marika Crescenzi
Roberto Vettor
Marco Rossato

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1251035

1,644 views
1 citation

Editorial

Published on 17 Oct 2023

Editorial: Global excellence in inflammation pharmacology

in Inflammation Pharmacology

Sukanya Saha
Shatadal Ghosh

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1307503

2,757 views

Systematic Review

Published on 17 Oct 2023

A systematic review and meta-analysis of loratadine combined with montelukast for the treatment of allergic rhinitis

in Inflammation Pharmacology

Huan Wang
Qing Ji
Chao Liao
Li Tian

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1287320

6,250 views
7 citations

Original Research

Published on 13 Oct 2023

Evaluation of anti-inflammatory and immunomodulatory potential of Lawsone (2-hydroxy-1,4-naphthoquinone) using pre-clinical rodent model of rheumatoid arthritis

in Inflammation Pharmacology

Sara Sattar
Arham Shabbir
Muhammad Shahzad
Tasleem Akhtar
Syed Muneeb Anjum
Mohammed Bourhia
Hiba-Allah Nafidi
Yousef A. Bin Jardan
Musaab Dauelbait
Aisha Mobashar

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1279215

3,049 views
6 citations